Search
for
Sort by
Research 931–960 of 1000+
- Efficacy of combination therapy of inositols, antioxidants and vitamins in obese and non-obese women with polycystic ovary syndrome: an observational study
- Lipid droplets and associated proteins in sebocytes
- A Review of Hand-Held, Home-Use Cosmetic Laser and Light Devices
- The Suitability of Polycystic Ovary Syndrome-Specific Questionnaires for Measuring the Impact of PCOS on Quality of Life in Clinical Trials
- Clinical Profiles, Occurrence, and Management of Adolescent Patients with HAIR-AN Syndrome
- Ovarian hormones and adrenal androgens during a woman's life span
- [Prevalence of cutaneous lesions in Freixo de Espada à Cinta].
- HORMONAL THERAPY IN DERMATOLOGY
- Pharmacological basis for clinical use of antiandrogens
- Polycystic ovary syndrome patients with high BMI tend to have functional disorders of androgen excess: a prospective study
- Dehydroepiandrosterone for women in the peri- or postmenopausal phase
- Dermatological Manifestations of Stress in Normal and Psychiatric Populations
- Managing Cutaneous Manifestations of Hyperandrogenic Disorders
- Androgenic effects of oral contraceptives: Implications for patient compliance
- Sebaceous immunobiology - skin homeostasis, pathophysiology, coordination of innate immunity and inflammatory response and disease associations
- Colchicine in Managing Skin Conditions: A Systematic Review
- Dermatologic Conditions in Transgender Populations
- Polycystic Ovary Syndrome: A Common Reproductive and Metabolic Disorder Necessitating Early Recognition and Treatment
- Spectrum of skin diseases in Yemen (Hajjah and adjacent region)
- Pharmacologic Treatment of Polycystic Ovary Syndrome
- Androgen physiology and the cutaneous pilosebaceous unit.
- 5α‐Reductase inhibitors and prostatic disease
- Stress and the skin: Significance of emotional factors in dermatology
- Microneedling in Dermatology: A Comprehensive Review of Applications, Techniques, and Outcomes
- Dermatology in black skin
- Efficacy and Safety of Baricitinib in Patients with Severe Alopecia Areata over 52 Weeks of Continuous Therapy in Two Phase III Trials (BRAVE-AA1 and BRAVE-AA2)
- Cannabinoids for skin diseases and hair regrowth
- Comparative Analysis of Machine Learning Algorithms in Diagnosis of Polycystic Ovarian Syndrome
- Diagnosis and Management of Polycystic Ovary Syndrome in Adolescent Girls
- Ultraviolet B irradiation increases the expression of inflammatory cytokines in cultured sebocytes